•  
  •  
  •  
  •  

2026-02-15 02:26:30

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth

Keywords Selected:  MPC

Research

  • Mr. Dhiraj Relli, MD & CEO, HDFC Securities, commentary on RBI Monetary Policy
  • Acuité Ratings & Research comments on RBI MPC Dec'22
  • Rise in food prices reverses three-month downtrend in CPI inflation - CPI Aug-22 - Acuité Ratings
  • Acuité continues to expect the RBI to hike repo rate by 50 bps in FY23 - RBI MPC April'22
  • RBI prioritizes inflation over growth, Acuité expects inflation to average at 5.9% in FY23 - MPC review - April'22
  • RBI retains accommodative stance for now, revises it's inflation and growth forecast for FY23 upwards
  • RBI plays it cautious, repo rates unchanged - Anuj Puri, Chairman - ANAROCK Group
  • MPC likely to continue on the accommodative path in near term - Acuité Ratings
  • Economy: RBI MPC: normalization by stealth to continue - Kotak
  • Views on announcements related to UPI payments in the RBI monetary policy today
  • Views on RBI Policy: Mr. Deepak Jasani, Head of Retail Research, HDFC Securities
  • Monetary Policy - MPC maintains status quo - Comments from Industry Leaders
  • Inflationary pressures are likely to be higher in the next few quarters - Acuite Ratings
  • Baby steps in the path of gradual normalization - Acuite Ratings

Market Commentary

  • Pre-Monetary Policy View - Jun 2022 - Kotak Mahindra Bank Ltd

Stock Report

  • Tahmar Enterprises Ltd receives renewal consent to operate 45 KLPD distillery
  • DoT grants UL VNO-GMPCS to Nelco Ltd
  • Medico Remedies Ltd gets GMP Compliance certificate from SMDC, Ukraine
  • Innova Captab Limited updates on SMDC inspection
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • AXISCADES Aerospace & Technologies Pvt Ltd receives order from Indian Army
  • Aarti Drugs Limited receives order from MPCB for closure of process at Tarapur unit
  • Kesar Petroproducts Ltd receives CTO from MPCB for its 1.5 MW Co-Gen power plant
  • Nectar Lifesciences Ltd's Unit VI gets CGMP certification from SMDC
  • Lupin achieves GMP Certification from TGA Australia for Dabhasa API Facility
  • Gland Pharma Ltd receives GMP compliance from Danish Medicines Agency
  • Shilpa Medicare Ltd's Unit VI, Dabaspet, Bengaluru receives GMP Certification from SFDA, Saudi Arabia
  • India Glycols Ltd receives GMP Certification from NSF International
  • Canara Bank reduces Repo Linked Lending rate in line with the RBI MPC
  • Wanbury's Tanuku facility granted Good Manufacturing Practices Certificate by ANVISA
  • Europe (AGES, Austria) Inspection of Shilpa Biologicals Pvt Ltd
  • Banganga Paper Mills receives Renewed Environmental Certification From MPCB
  • OneSource Specialty Pharma Ltd secures Brazilian GMP approval for its flagship facility Unit 2
  • Venus Remedies Ltd receives GMP certification from Moldova
  • Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
  • Techknowgreen Solutions Ltd receives order worth Rs. 2.06 crore from MPCB
  • Concord Biotech Limited gets EUGMP Certificate for Valthera Facility
  • IOL Chemicals and Pharmaceuticals Ltd receives GMP Certificate issued by Brazilian Health Regulatory Agency ANVISA
  • Techknowgreen Solutions Ltd receives order

Industry News

  • Realtors welcome continuation of low home loan interest rates in latest RBI MPC

Latest Post

  • Anupam Rasayan Delivers Strong Q3 FY26 Performance
  • Hind Rectifiers Posts Record Q3 FY26 Revenue
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025